Please enjoy our September Industry Highlights!
NemaLife, Inc.
Biotechnology Research
Lubbock, Texas 2,999 followers
A techbio platform company developing AI & microfluidics-based in vivo, in vitro & protein characterization solutions.
About us
NemaLife's mission is to accelerate and de-risk R&D for companies in the food, nutraceutical, microbiome and pharma industries. In these industries, performing human-relevant high throughput biology and doing so with efficiency and speed has been a mutually exclusive affair. NemaLife has solved this major challenge by developing an AI-assisted microfluidics-based in vivo platform based on the microscopic worm C. elegans that has strong relevance for human biology. This 3R-compliant cruelty-free technology capable of testing a variety of compounds and their combinations is an alternative to expensive and time-consuming mouse models. We work with companies as their R&D partner, accelerating the value-chain from early-phase discovery to assessment of product potency and health claims. Our interdisciplinary team of engineers and biologists work with you to achieve your R&D objectives as well as co-create assets by developing custom biological readouts and new tech platforms. We have significant pre-clinical expertise in human wellness areas related to gut health, brain health, muscle health, metabolic health, cognitive health and healthy aging. We would be happy to share more details in a 15 min call.
- Website
-
http://www.nemalifeinc.com
External link for NemaLife, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Lubbock, Texas
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Aging, Disease Modeling, Drug discovery, Transgenics, Longevity, Lifespan, Healthspan, Screening, Microbiome, Neurodegeneration, Toxicity, In vivo assays, C. elegans, Functional food ingredients, Prebiotics, Probiotics, Postbiotics, Microfluidics, and Machine Learning
Locations
-
Primary
3911 4th St
Lubbock, Texas 79415, US
Employees at NemaLife, Inc.
-
Nimisha Srivastava
-
Grant Campany
Chief Financial Officer | Chief Business Officer | Board Member
-
Martin Kussmann, PhD
Leveraging nutrition and the converging revolutions in biotechnology and informatics to improve human health and make the food system more sustainable
-
M. Adnan Qureshi
Discovery Team Lead at NemaLife Inc.
Updates
-
For decades, the mouse has been the gold standard in preclinical research. But as science, industry, and society evolve, so do the tools we use to understand human biology. At NemaLife, we believe a new contender is emerging – one that is tiny, transparent, and often overlooked: 𝘊𝘢𝘦𝘯𝘰𝘳𝘩𝘢𝘣𝘥𝘪𝘵𝘪𝘴 𝘦𝘭𝘦𝘨𝘢𝘯𝘴, a nematode. As we push toward more ethical, scalable, and cost-effective alternatives, 𝘊. 𝘦𝘭𝘦𝘨𝘢𝘯𝘴 might just be the future of preclinical screening. With decades of research supporting its relevance to human biology, the explosive growth of AI in data processing, and increasing momentum from regulatory agencies and animal welfare groups, the time is ripe for this disruption. To learn more, check out our latest blog! Read More: https://lnkd.in/gtGuX3Wf #PreclinicalResearch #Celegans #HumanHealth #FunctionalIngredients #InnovationInScience #AIinScience #R&D #FutureOfHealth
Is the Worm the New Mouse?
nemalifeinc.com
-
Recent consumer insights show that intent to purchase supplements increases by 15% when the number of health benefits rises from one to three. With 𝐍𝐞𝐦𝐚𝐋𝐢𝐟𝐞’𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐅𝐥𝐲𝐰𝐡𝐞𝐞𝐥, you can screen for six health benefits at the same time! Our preclinical platform doesn’t just identify one benefit in your bioactive ingredient, it uncovers potential in Cognitive Health, Metabolic Health, Muscle Performance, Gut Health, Stress Resilience, and Healthy Aging—all in one streamlined process. Maximize the impact of your ingredients and give consumers the multi-benefit solutions they’re looking for. 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬: [email protected] Want to read more? Use the links down below. 𝐕𝐞𝐫𝐛 𝐁𝐢𝐨𝐭𝐢𝐜𝐬 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: https://lnkd.in/gfDzjNyA 𝐍𝐮𝐭𝐫𝐚 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬 𝐀𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/gsw5MfbR 𝐍𝐞𝐦𝐚𝐋𝐢𝐟𝐞’𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐅𝐥𝐲𝐰𝐡𝐞𝐞𝐥: https://lnkd.in/gUpjiWsy #Bioactives #PreclinicalScreening #HealthBenefits #DiscoveryFlywheel #SupplementScience
-
Today, we pause to remember the lives lost, the heroes who emerged, and the resilience shown on September 11, 2001. As we honor the memory of those who were taken from us, we also reflect on the courage, unity, and compassion that brought us together in the face of unimaginable tragedy. Let us continue to support one another and carry forward the spirit of hope and perseverance that defines us. #NeverForget #911Remembrance #HonorAndRemember #Unity
-
The one chip that rules them all! We often are asked as to how we create magic with our organism-on-chip bioactive discovery platform which evaluates botanicals, phytonutrients, probiotics, postbiotics, dietary proteins, vitamins etc. Our Infinity Chip is the magical microfluidic device that mimics the natural, soil-like environment that nematodes are accustomed to, allowing them to live a full lifespan without the stress induced by conventional methods. Unlike agar plates, which require multi-day maintenance and manual transfers to prevent progeny from confounding data, our Infinity Chips utilize around 40,000 pillars and size-selective filters. This design allows for the removal of progeny through fluid flow while retaining adult nematodes, ensuring an age-synchronous population. The simplification of organismal husbandry along with the optical transparency of the Infinity Chip enables our visual AI to quantify diverse phenotypes, creating magic with our platform. #OrganismOnChip #Microfluidics #Innovation #IngredientDiscovery #Nematodes
-
At NemaLife, we're committed to accelerating the discovery of natural bioactive solutions that can drive impactful health outcomes. Our cutting-edge technology provides rapid, 𝘪𝘯 𝘷𝘪𝘷𝘰 evidence to validate the benefits of novel functional ingredients. We're curious to know which health benefits you believe should be prioritized in the race for innovative, science-backed solutions. Cast your vote in our poll below and help shape the future of bioactive discovery and ingredient innovation! #Bioactives #PreclinicalResearch #HealthBenefits #Innovation #LifeSciences
This content isn’t available here
Access this content and more in the LinkedIn app
-
At NemaLife, we are dedicated to advancing the field of healthy aging with our cutting-edge, AI-assisted platforms. We’re honored to have long-term partners like Michael Petrascheck who share our vision for pushing the boundaries of what's possible in aging science. Our organism-on-chip platform based on 𝘊. 𝘦𝘭𝘦𝘨𝘢𝘯𝘴 is designed to deliver high-resolution insights into the effects of bioactives. Performing whole-life studies is easy at NemaLife, as it eliminates the tedious process of transferring worms or the use of progeny-blocking drugs like FuDR. This capability opens up new avenues for testing and innovation in the longevity space. Reach out to us to uncover the next generation of longevity compounds and drive meaningful progress in healthy aging. #HealthyAging #Nematodes #Bioactives #Nematode #Innovation #Techbio #PreclinicalResearch
-
We are thrilled to highlight how NemaLife's Discovery Flywheel is paving the way for breakthroughs in longevity and healthspan research. At NemaLife, we are committed to developing natural solutions to extending healthspan with our cutting-edge technologies. Our proprietary AI-assisted nematode-based platform allows us to screen bioactives that promote healthy aging and extend lifespan. Leveraging our visual AI-powered analysis, we deliver geroprotectors with #LivingProof. Connect with us to learn how our Discovery Flywheel can accelerate your product development to new heights. #Longevity #Healthspan #HealthyAging #TechBio #PreclinicalResearch #Nematodes #Innovation #HealthScience
-
Please check out our latest industry highlights for August! ☀
Exploring the Safety of Rare Cannabinoids, Enhancing Plant-Based Proteins, and The Anti-Aging Power of Fasting.
NemaLife, Inc. on LinkedIn
-
At NemaLife, we're pushing the boundaries of bioactives research by shining a spotlight on the potential of understudied cannabinoids. Our latest blog reveals how we're using AI-driven preclinical screening tools to accelerate the data-generation on the safety and efficacy of lesser-known compounds. By utilizing our organism-on-chip platform involving 𝘊. 𝘦𝘭𝘦𝘨𝘢𝘯𝘴 model, microfluidics and visual AI, we're uncovering how safe and effective these cannabinoids can be. Curious about how these understudied cannabinoids could shape the future of human health and wellness? Click the link here to read more: https://lnkd.in/gK7AGibx #Cannabinoids #Innovation #Biotech #HealthTech #AI #Bioactives #NemaLife
Exploring the Safety and Efficacy of Rare Cannabinoids Using an AI-enabled High Throughput In vivo Model
nemalifeinc.com